Numbers by Barron's

Apple Closes in on a $3 Trillion Valuation

Episode Summary

Apple stock is up more than 40% in a year. Merck and Pfizer spin-offs are the two cheapest stocks in the S&P 500. And China’s Didi plans to delist shares in the U.S.

Episode Notes

Apple stock is up more than 40% in a year. Merck and Pfizer spin-offs are the two cheapest stocks in the S&P 500. And China’s Didi plans to delist shares in the U.S.